ArticleBMC public health2025
Post-Covid-19 symptoms, subjective work ability and sick leave 2 years after acute infection-results from a population-based long COVID study.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The impact of SARS-CoV-2 infection on work participation, sickness absence and general practitioner consultations in the Danish population - a register-based matched cohort study.BMC public health · 2026Article
- Associated factors and predictive nomogram of long COVID: a cross-sectional study in China.BMC pulmonary medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe post-COVID syndrome (PCS) is associated with reduced work ability, increased sick leave and delayed return to work. Yet, the relationship is complex due to a heterogeneous set of PCS symptoms and the multifaceted nature of work ability.
methodsBased on a population-based longitudinal study (n = 5422, 18-65 years) conducted in the Southwest of Germany, we describe the evolution of work ability (mWAI1), task-related work ability (mWAI2), and sick leave 6-12 and 24 months after a SARS-CoV-2 index infection and confirmed by Polymerase Chain Reaction. Descriptive analyses on mWAI1 and mWAI2 and adjusted linear regression analyses were performed.
results1.1% of our population was continuously on sick leave since the initial SARS-CoV-2 infection (about 24 months after the infection). Pre-infection mWAI1 was not regained due to persisting or newly occurring symptoms of fatigue, neurocognitive impairment and anxiety/depression/sleep disorders that were related also to lower mWAI2. Effect modifiers of the associations between risk factors and mWAI1 or mWAI2 were age, working tasks, and comorbid mental conditions. Further SARS-CoV-2 infections were associated with poorer mWAI2 in physically (regression coefficient, 95% confidence intervals: -3.45 (-6.15,-0.74) but not mentally working participants (0.20 (-0.54,0.95)) and age proved to be a stronger risk factor for mWAI2 in physically working subjects.
conclusionsWe confirmed known risk factors but further emphasized effect modifiers like working task or comorbid mental disorders for work ability and described variables related to sick leave after SARS-CoV-2 infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.